Xiao Han
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$10.4MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $10.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 6, 2022 | NIH | SBIR Phase II Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $767K | CLARIX IMAGING CORP |
| Aug 27, 2021 | NIH | SBIR Phase II Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $1.5M | CLARIX IMAGING CORP |
| Jul 2, 2020 | NIH | SBIR Phase II Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $1.8M | CLARIX IMAGING CORP |
| Jul 2, 2020 | NIH | SBIR Phase II Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $4.0M | CLARIX IMAGING CORP |
| May 13, 2019 | NIH | SBIR Phase II Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $1.0M | CLARIX IMAGING CORP |
| Apr 11, 2018 | NIH | SBIR Phase II Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $920K | CLARIX IMAGING CORP |
| Sep 1, 2016 | NIH | SBIR Phase I Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $225K | CLARIX IMAGING CORP |
| Aug 26, 2016 | NIH | SBIR Phase I Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment | $225K | CLARIX IMAGING CORP |
Peer ranks
Federal funding#69
Awards as PI#216
Patents#505
Companies
- CLARIX IMAGING CORPLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.